相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel therapeutic agents for B-cell lymphoma: developing rational combinations
Craig B. Reeder et al.
BLOOD (2011)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
A Multitude of Kinases-Which are the Best Targets in Treating Rheumatoid Arthritis?
Tamsin M. Lindstrom et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2010)
Primary B Cell Immunodeficiencies: Comparisons and Contrasts
Mary Ellen Conley et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Tyrosine kinases as targets for the treatment of rheumatoid arthritis
Christina D'Aura Swanson et al.
NATURE REVIEWS RHEUMATOLOGY (2009)
Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals
Masahiro Shinohara et al.
CELL (2008)
Cell signalling in macrophages, the principal innate immune effector cells of rheumatoid arthritis
Stefan K. Drexler et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Fc gamma receptors as regulators of immune responses
Falk Nimmerjahn et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor
Polly R. Pine et al.
CLINICAL IMMUNOLOGY (2007)
Histamine release from human buffy coat-derived mast cells
Xian Song Wang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2007)
A protocol for generating high numbers of mature and functional human mast cells from peripheral blood
J. Lappalainen et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2007)
R406, an orally available spleen tyrosine kinase inhibitor blocks Fc receptor signaling and reduces immune complex-mediated inflammation
Sylvia Braselmann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma. B cells from tumor-infiltrating nonmalignant B cells
Jonathan M. Irish et al.
BLOOD (2006)
Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes
Rebeca Perez de Diego et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Activation of human mast cells by aggregated IgG through FcγRI:: additive effects of C3a
MR Woolhiser et al.
CLINICAL IMMUNOLOGY (2004)
Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses
A Mangla et al.
BLOOD (2004)
Targeting Syk as a treatment for allergic and and autoimmune disorders
BR Wong et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Quantitative Analysis of Micro-CT Imaging and Histopathological Signatures of Experimental Arthritis in Rats
Matthew D. Silva et al.
MOLECULAR IMAGING (2004)
Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor at production
NJ Horwood et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Evolving concepts of rheumatoid arthritis
GS Firestein
NATURE (2003)
Arthritis critically dependent on innate immune system players
H Ji et al.
IMMUNITY (2002)
Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase
WN Khan
IMMUNOLOGIC RESEARCH (2001)
Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors
DM Wang et al.
IMMUNITY (2000)
A sensitized genetic system for the analysis of murine B lymphocyte signal transduction pathways dependent on Bruton's tyrosine kinase
AB Satterthwaite et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
